Influenza and pneumococcal vaccinations are recommended as part of a COPD risk reduction strategy. In particular, influenza vaccination has been shown to prevent acute respiratory infections in patients with different stages of COPD. Therefore, in our intervention program, subjects were instructed to obtain influenza and pneumococcal vaccinations along with immunomodulatory agents, which may improve a subject’s immune system.